Yumab is a startup based in Germany.
Yumab develops and engineers therapeutic antibodies using proprietary antibody libraries and discovery platforms to support the development of novel biopharmaceuticals.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.